ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ARWR Arrowhead Pharmaceuticals Inc

28.70
0.00 (0.00%)
Pre Market
Last Updated: 08:19:48
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1
Bid Price 28.55
Ask Price 28.96
News -
Day High

Low
20.67

52 Week Range

High
42.48

Day Low
Company Name Stock Ticker Symbol Market Type
Arrowhead Pharmaceuticals Inc ARWR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 28.70 08:19:48
Open Price Low Price High Price Close Price Prev Close
28.70
Trades Volume Avg Volume 52 Week Range
1 1 - 20.67 - 42.48
Last Trade Time Type Quantity Stock Price Currency
08:01:43 1 $ 28.77 USD

Arrowhead Pharmaceuticals (ARWR) Options Flow Summary

Overall Flow

Bearish

Net Premium

-62k

Calls / Puts

0.00%

Buys / Sells

0.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Arrowhead Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
3.56B 123.90M - 240.74M -205.28M -1.66 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Arrowhead Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ARWR Message Board. Create One! See More Posts on ARWR Message Board See More Message Board Posts

Historical ARWR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week28.9729.9327.1827.97716,279-0.27-0.93%
1 Month34.5036.7227.0030.551,407,232-5.80-16.81%
3 Months32.6339.8327.0032.781,591,116-3.93-12.04%
6 Months26.3339.8320.6729.721,435,8642.379.00%
1 Year24.2542.4820.6730.851,195,4844.4518.35%
3 Years62.5793.6620.6740.75934,123-33.87-54.13%
5 Years17.7893.6617.2542.141,155,15910.9261.42%

Arrowhead Pharmaceuticals Description

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Your Recent History

Delayed Upgrade Clock